Interference with TGF-beta1 and -beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma.
about
Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretionFibroblast EXT1-levels influence tumor cell proliferation and migration in composite spheroidsHigh interstitial fluid pressure - an obstacle in cancer therapyCollagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.Stromal regulation of vessel stability by MMP14 and TGFbeta.The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cellsIntratumoral drug delivery with nanoparticulate carriers.Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment.Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in miceAngiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Targeting TGF-β Signaling for Therapeutic Gain.Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress.Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.Peritumoral TNFalpha administration influences tumour stroma structure and physiology independently of growth in DMBA-induced mammary tumours.Drug delivery: Redefining tumour vascular barriers.High-dose, short-term, anti-inflammatory treatment with dexamethasone reduces growth and augments the effects of 5-fluorouracil on dimethyl-alpha-benzanthracene-induced mammary tumors in rats.Inhibition of integrin αVβ6 changes fibril thickness of stromal collagen in experimental carcinomas.
P2860
Q28573223-C852D000-C049-4CEC-9BEA-7EE6B8106B66Q28728778-866E0D91-4B46-477D-B995-38D21AE5F3AFQ29619719-95BCB834-5E0F-44C2-80DB-863E198E9EDDQ33294967-1B7D30AF-8ADF-4B7E-B154-5EC2150EB2F0Q33815414-1012283F-C698-4A72-B3A2-CA2F6BDDF9E5Q34832951-D67E12FC-66BC-4F46-8B67-538AB06EE2E2Q35091415-DB5DE04C-4C58-4A74-8EE0-305ED91CE09CQ36095644-879488A7-4462-4F85-A640-D75312408732Q37013337-1E36149F-0C1E-4A2E-965A-B30F84E69099Q37426354-3F22C5FF-989D-48D3-BB19-10E8140DB73DQ38130312-D733E508-8A83-4C08-950B-390E10F88B25Q38682486-A9F5D7FC-6315-407F-A40F-FF3532D4E571Q39155151-3276B2EB-EFA1-455F-9257-ECF664A04C3EQ39346123-C3486394-FF58-474E-AACF-8167BEA1FD0BQ41475309-E71FB3CF-5B82-4F30-84B0-7D957E36C168Q46044956-BD7905AE-9C79-4770-AAA6-4C39966FF126Q46234327-C7D5CF50-64E3-4628-81EB-F8F323912FFDQ51784672-B05025C3-85A1-4F04-97FF-B7089CEBB47CQ55475652-8F3CCEB2-C3E6-40EF-AC2A-60D83022B32F
P2860
Interference with TGF-beta1 and -beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Interference with TGF-beta1 an ...... wth in experimental carcinoma.
@ast
Interference with TGF-beta1 an ...... wth in experimental carcinoma.
@en
type
label
Interference with TGF-beta1 an ...... wth in experimental carcinoma.
@ast
Interference with TGF-beta1 an ...... wth in experimental carcinoma.
@en
prefLabel
Interference with TGF-beta1 an ...... wth in experimental carcinoma.
@ast
Interference with TGF-beta1 an ...... wth in experimental carcinoma.
@en
P2093
P356
P1476
Interference with TGF-beta1 an ...... owth in experimental carcinoma
@en
P2093
Christian Sundberg
Ellen Lammerts
Kristofer Rubin
Nils-Erik Heldin
Pernilla Roswall
Philip J Gotwals
Victor E Koteliansky
P304
P356
10.1002/IJC.10722
P50
P577
2002-12-01T00:00:00Z